Collectively, above data-driven results suggest that DNA methylation are associated with the downregulation of ADHFE1 in breast cancer, and decreased ADHFE1 is a risky factor of patient survival in breast cancer. This evidence concerns the gene ADHFE1 and breast carcinoma.